Ocugen (OCGN) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2026)
Ocugen (OCGN) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PP&E (Net) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-14.40% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3.41% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
13.10% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ocugen |
411.07 Mn |
411.07 Mn |
- |
20.26% |
| Date | Value |
|---|
| Mar 31, 2026 |
20.26% |
| Dec 31, 2025 |
33.47% |
| Sep 30, 2025 |
49.01% |
| Jun 30, 2025 |
69.83% |
| Mar 31, 2025 |
102.66% |
| Dec 31, 2024 |
142.28% |
| Sep 30, 2024 |
153.46% |
| Jun 30, 2024 |
164.53% |
| Mar 31, 2024 |
185.08% |
| Dec 31, 2023 |
201.16% |
| Sep 30, 2023 |
307.32% |
| Jun 30, 2023 |
269.48% |
| Mar 31, 2023 |
217.27% |
| Dec 31, 2022 |
200.77% |
| Sep 30, 2022 |
176.69% |
| Mar 31, 2022 |
142.32% |
| Dec 31, 2021 |
67.93% |
| Sep 30, 2021 |
-37.71% |
| Jun 30, 2021 |
-43.28% |
| Mar 31, 2021 |
-44.46% |
